Indian Drug Price Regulator Opposes Plans To Clip Its Wings
Executive Summary
An Aug. 30 stakeholder meeting on India’s contentious draft pharmaceutical policy was an unusual mix of radical suggestions, simmering tensions and a changed agenda. With voices of opposition growing, including from within the government, it’s unlikely to be smooth sailing for the draft, at least in its current form.
You may also be interested in...
Has India’s Drug Pricing Authority Been Rendered Toothless?
India has put in place a new panel to act as a 'recommending body' to the National Pharmaceutical Pricing Authority, raising questions about the pricing body’s autonomy and whether its role has been 'usurped'. The pharma industry claims a balanced pricing regime may emerge under the new system but doesn’t rule out inter-department conflicts in the government.
India’s Pricing Authority Head Shunted Out?
India’s firebrand pharma pricing authority chief has been transferred out amid sharply polarized views on either side of the debate around his controversial stint.
India’s Pricing Authority Head Shunted Out?
India’s firebrand pharma pricing authority chief has been transferred out amid sharply polarized views on either side of the debate around his controversial stint.